Navigation Links
Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
Date:3/6/2013

MALVERN, Pa., March 6, 2013 /PRNewswire/ -- Michael Hickey, former Vice President of US Sales at AstraZeneca and former President of AstraZeneca, Netherlands has recently joined Delta Point , Inc. as Senior Vice President of Global Leadership Development. "Michael is a perfect fit for the future direction of Delta Point as we focus on the sales leadership required for the delivery of exceptional sales performance," explained Jerry Acuff , founder and CEO of Delta Point. "Developing the expertise of the sales leaders and especially sales managers translates to increased bottom line results for our customers."

Michael Hickey graduated from University College Dublin with a degree in Pharmacy, an MSc in Pharmaceutical Chemistry and an MBA.  He also completed residential advanced management programs in strategic marketing in Harvard University and the AMP in INSEAD, France. 

Michael Hickey has a deep understanding of the pharmaceutical business having worked in the industry for 30 years in many and varied functions such as production, clinical research, marketing, sales and senior management in the US, Canada and a number of European countries. 

During his time as VP Sales in the US, he successfully led the successful launch of megabrands such as Crestor, Seroquel and Nexium and also a number of oncology brands.  His innovative and creative approach led to the introduction of a new AZ selling model in the US and also in the Netherlands and to the introduction of a comprehensive SFE (Sales Force Effectiveness) program in the US which was later adopted worldwide.   Following his time with AZ, Michael became President of IBA Molecular, North America, a leading radiopharmaceutical company. 

About Delta Point , Inc.

Headquartered in Scottsdale, AZ with a regional office in Malvern, PA, Delta Point , Inc. specializes in the life sciences industry (pharmaceutical, biotech, and device companies) by partnering with clients to maximize brand sales performance. Their focus is on improving outcomes by analyzing the needs of their customers before developing customized recommendations that align cross-functional departments: Sales, Marketing, Sales Training and Commercial Operations. Delta Point specializes in making those changes that help corporations deal with the challenges they face whether it is launching a new product or an underperforming brand by working with Marketing, Sales Management, Sales Training and Sales Operations as a partner in attaining business success. They have gained recognition for developing strategic sales and marketing plans, improving sales messaging, and for the effectiveness of their training programs, including a copyrighted process of building, sustaining and growing substantive business relationships.

Contact:
Jerry Acuff , CEO
Delta Point , Inc.
480-296-9972
Email

http://www.gottochange.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Delta Point , Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Adam Chasse Inducted Into Delta Omega Public Health Honorary Society
2. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
3. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
4. Creabilis Appoints Catherine Moukheibir to its Board of Directors
5. Janet Kreizman Appointed Chief Executive Officer of AACC
6. Verenium Appoints Holger Liepmann To Its Board Of Directors
7. Ancient Egyptian blue pigment points to new telecommunications, security ink technology
8. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
9. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
10. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
11. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market ... 2013. The market is expected to grow at a five-year compound ... from $50.6 billion in 2015 to $96.6 billion in 2020. ... (2015 to 2020) are discussed. As well, new products approved in ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016   ... the first pluripotent stem cell-derived islet replacement therapy for ... two presentations at ISSCR 2016 Annual Meeting.  ISSCR 2016, ... 22nd to 25th at Moscone West in San Francisco.  ... Details of the presentations are as follows:Event: , Focus ...
Breaking Biology Technology:
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):